Prism facilitated the sale of Sonaspection International Limited, a leading NDT calibration samples manufacturer, to private investor Athanasia Investments LLP.
Information on the Target
Sonaspection International Limited (Sonaspection) is a leading manufacturer of flawed specimens within the non-destructive testing (NDT) and evaluation (NDE) industry, recognized for its longstanding presence and expertise in the field. The company is internationally acknowledged as a benchmark for NDT training and qualification, providing crucial products and services that support the effective calibration of NDT equipment.
Based in Lancaster, UK, with an additional site in Charlotte, USA, Sonaspection specializes in producing materials intentionally flawed through methods such as welding, casting, and forging. These specimens are essential for NDT equipment calibration and training, ensuring professionals in the industry are equipped with the right tools and knowledge to perform their roles effectively.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The non-destructive testing (NDT) industry is crucial across numerous sectors, including aerospace, manufacturing, and infrastructure, where safe and reliable operation is paramount. The rising demand for safety regulations an
Similar Deals
WayBeyond Capital Ventures Ltd → Earthworks Testing Ltd
2025
Employee Ownership Trust → Greenhatch Group
2024
Pemberstone Capital Partners Limited → Sterling Thermal Technology Ltd
2024
Carpenter Oak Build Limited → Xylotek Limited
2024
Foresight Group → Martek Marine Ltd
2024
Athanasia Investments LLP
invested in
Sonaspection International Limited
in 2025
in a Management Buyout / Buy-In (MBO) deal